Many patients who claim to have penicillin allergies may not actually be allergic to the antibiotic.
Mylan Inc. today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® and EpiPen Jr® Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.
Allergy & Asthma Network today announced a unique collaboration at the ACAAI’s 2014 Annual Scientific Meeting in Atlanta. Both membership organizations will combine their specialized expertise and skills to help patients manage chronic conditions while updating health care professionals, pharmacies, and government officials about current best practices.